AI reads tumor slides to forecast cancer spread

NCT ID NCT07244094

Recruiting now Knowledge-focused Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study uses artificial intelligence to analyze standard tissue samples from breast cancer patients. The goal is to predict which patients are at higher risk of the cancer spreading to other parts of the body. Researchers will train the AI on slides from 400 women who had surgery between 2015 and 2025. If successful, this tool could help doctors personalize follow-up care and treatment decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
RECRUITING

Hangzhou, Zhejiang, China
Cancer Institute and Hospital, Tianjin Medical University, China
NOT_YET_RECRUITING

Tianjin, Tianjin Municipality, 300060, China
Jilin Cancer Hospital
NOT_YET_RECRUITING

Changchun, Jilin, 130000, China
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
NOT_YET_RECRUITING

Hangzhou, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.